Vaccines & Biologics
Kadcyla Powder for Concentrate for Solution for Infusion 160 mg 160 mg/8 ml
Powder for concentrate for solution for infusion
Pharmacies near you confirm whether they can supply it.
Strength: 160 mg/8 ml
Free to askNo payment until you accept
- You send the request — no prescription needed to ask.
- Pharmacies reply with what they have and the price.
- You accept one and pay — or you don’t.
Prescription medicine — your pharmacist will check what they need when you collect.
Manufactured by Roche Products Limited
Composition: Kadcyla 160 mg powder for concentrate for solution for infusion. One vial of powder for concentrate for solution for infusion contains 160 mg of Trastuzumab emtansine. After reconstitution, one vial of 8 mL solution contains 20 mg/mL of Trastuzumab emtansine. * Trastuzumab emtansine is an antibody-drug conjugate that contains trastuzumab, a humanised IgG1 monoclonal antibody produced by mammalian (Chinese hamster ovary) cell suspension culture, covalently linked to DM1, a microtubule inhibitor, via the stable thioether linker MCC (4-[N-maleimidomethyl] cyclohexane-1-carboxylate)
Pack sizes: 160 mg x 1's (in clear glass vial)
Generic names:
Always follow the product label. If symptoms persist, consult a pharmacist. Products are sold by licensed pharmacies on the platform.
Kadcyla Powder for Concentrate for Solution for Infusion 160 mg 160 mg/8 ml · 160 mg/8 ml
Prescription medicine